Different granules of these drugs prepared for compression showed good flow properties GDC-0068 mw with angle of repose values. The bulk and tapped densities, CI and HR revealed that all the formulation blends having good flow properties and flow rate than raw materials. In FTIR

spectrum of RAM blend, the absorption peaks were observed at 3438 cm−1 due to –NH and –OH stretching of acid, at 3026 cm−1 and 2938 cm−1 were due to –CH aromatic stretching. Peaks at 2866 cm−1 and 1743 cm−1 were due to –CH aliphatic stretching and –C O of acid respectively. In case of NFM blend, the appearance of strong absorption bands in the region of 3331 cm−1 was due to stretching vibrations of N–H free, stretching of Ar–H, (–CH) several band in the region of 3100 cm−1. 2842 cm−1 showed methyl group where C–C symmetric, in the region of 1680 cm−1, was due to C O stretching vibration. Peaks of NFM-loaded gelatin microcapsules (Fig. 4) were similar (but with lesser intensity) to the spectrum of NFM. When IR spectra of pure RAM and pure NFM were compared to the spectra of their blends, no differences were observed between the spectra. Furthermore, missing of bands and appearance of new bands in the IR spectra of blends were not observed. The DSC showed a sharp melting endotherm at 110 °C which is the melting point of RAM. Selleckchem MK2206 NFM exhibited a single melting point endotherm with an onset temperature

of 172 °C and an endothermic change in baseline following melting. This noteworthy variance in DSC pattern of gelatin microcapsule blend suggested that NFM was present in the amorphous Thymidine kinase form (Fig. 5). Different tablet formulations of RAM were prepared by wet granulation method. The tablet powder blends were studied for CI and HR. The tablets of different batches showed uniform thickness (3.16 ± 0.25 to 3.24 ± 0.14 mm) and diameter (6.25 ± 0.17 to 6.35 ± 0.20 mm).

The hardness was found to be 5.0 ± 0.3 to 5.1 ± 0.4 kg/cm2. The friability and weight variation were within the official limits of <1% and ±5%, respectively. RAM contents in core tablets were found to be 98.80 ± 0.31 to 99.25 ± 0.31%. The disintegration time taken by T1 tablet formulation was less than 15 min. The drug release was hasty in 8 h. Hence, in order to become slow release, the concentration of the polymer solution and the coating solution was increased in the formulation. Coating solution is generally used at a low level in the solid dosage form, typically 1–10% by weight relative to the total weight of the dosage unit. Eudragit was used to exhibit high resistance to acidic juices of stomach. The formulation T2 containing 10% HPMC and Eudragit 10% as its coating solution gave better resistance to acid but release profiles were not proper. Hence, the polymer concentration was increased to 15% and a double coating of Eudragit 10% was given which withstood the acidic pH of stomach and presented good CR profile. The formulation (T3) showed 80 ± 2.